Separate names with a comma.
HHS & VA Announce Bold, Comprehensive Partnership to Advance Rapid-Acting Mental Health Treatments for Veterans...
FDA sets public hearing on psychedelics for September 14 - Jefferies sees FDA willing to move on COMP360...
FDA sets public hearing on psychedelics for September 14...
CMPS Compass Pathways: A Structural Mispricing in Plain Sight? Extremely good explanation of the value of this company by a Stanford Professor....
From the most recent Financial Reporting Doc. We look to have been expanding into Europe... ---...
Psychedelics surge again as Compass, Definium provide more clinical validation...
Is This LSD Data Literally Mind-Blowing? [MEDIA]
Definium Therapeutics / DFTX: Interesting MOA Advisory Board Breadcrumb Found another small but potentially meaningful public breadcrumb for...
MA or Partner soon. [IMG]
Stifel raises Definium Therapeutics price target on MDD data...
Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile...
AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder July 6, 2026...
FDA Tracker flagged Definium’s Voyage Phase 3 GAD trial as having a July 1, 2026 primary completion date for NCT06741228. FDA Tracker notes...
GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech. Jazz Pharmaceuticals...
Bipartisan Congressional Bill Would Codify Trump’s Psychedelics Order Into Law...
